Showing 1,161 - 1,180 results of 21,625 for search '(( significant ((changes decrease) OR (sharp increase)) ) OR ( significant decrease decrease ))', query time: 0.37s Refine Results
  1. 1161
  2. 1162
  3. 1163
  4. 1164
  5. 1165
  6. 1166
  7. 1167

    Table 1_Overexpression of TaPSKR1L-6A improves resistance to sharp eyespot and increases lignin accumulation in wheat.docx by Haijun Qi (11611600)

    Published 2025
    “…Overexpression of TaPSKR1L-6A significantly increased sheath blight resistance, upregulated the expression of lignin synthesis and metabolism pathway genes, and increased lignin accumulation, which was opposite to the results of silencing TaPSKR1L-6A. …”
  8. 1168
  9. 1169
  10. 1170

    Changes in the white blood cell count. by Lu Yang (30847)

    Published 2025
    “…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”
  11. 1171

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  12. 1172
  13. 1173
  14. 1174
  15. 1175

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  16. 1176

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
  17. 1177
  18. 1178
  19. 1179
  20. 1180